|
ASCO GU: No Help from Continuous Tx in Metastatic RCC - MedPage Today |
|
|
MedPage Today
ORLANDO -- Outcomes in metastatic renal cell carcinoma did not improve with continuous dosing of sunitinib (Sutent) compared with the conventional 4/2 dosing regimen, results of a multicenter randomized
|